Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo area

Forensic Toxicology

Volumn 30, Issue 1, 2012, Pages 33-44

  Nakajima, Jun'Ichi ^a   Takahashi, Misako ^a   Seto, Takako ^a   Yoshida, Masao ^a   Kanai, Chieko ^a   Suzuki, Jin ^a   Hamano, Tomoko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

(1 (4 Pentenyl) 1H indol 3 yl)(naphthalen 1 yl)methanone; AM 2202; Designer drug; JWH 203; Mitragynine; Synthetic cannabinoids

Indexed keywords

[1 (4 PENTENYL) 1H INDOL 3 YL] (NAPHTHALEN 1 YL)METHANONE; [1 (5 HYDROXYPENTYL) 1H INDOL 3 YL] (NAPHTHALEN 1 YL)METHANONE; CANNABINOID; CANNABINOID RECEPTOR; HERBACEOUS AGENT; JWH 019; JWH 210; METHANOL; MITRAGYNINE; NAPHTHOYLINDOLE DERIVATIVE; NEW DRUG; NON PRESCRIPTION DRUG; SILICA GEL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SURVEILLANCE PROGRAM; HERBAL MEDICINE; ISOMERISM; JAPAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OFF LABEL DRUG USE; PHYTOCHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STUDY; SOLVENT EXTRACTION; STRUCTURE ACTIVITY RELATION; ULTRASOUND; ULTRAVIOLET SPECTROSCOPY;

EID: 84858705044     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-011-0130-5     Document Type: Article

References (18)

1. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y (2009) Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 57:439-441
2. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61-66
3. Kikura-Hanajiri R, Kawamura M, Maruyama T, Kitajima M, Takayama M, Goda Y (2009) Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant "kratom" (Mitragyna speciosa) by LC-ESI-MS. Forensic Toxicol 27:67-74
4. Kikuchi H, Uchiyama N, Ogata J, Kikura-Hanajiri R, Goda Y (2010) Chemical constituents and DNA sequence analysis of a psychotropic herbal product. Forensic Toxicol 28:77-83
5. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 29:25-37
6. Nakajima J, Takahashi M, Seto T, Suzuki J (2011) Identification and quantitation of cannabimimetic compound JWH-250 as an adulterant in products obtained via the Internet. Forensic Toxicol 29:51-55
7. Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol- 3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95-110
8. 35S]GTPγS binding assays. Forensic Toxicol 29:132-141
9. EMCDDA (2010) Europol 2010 Annual Report on the implementation of Council Decision. http://www.emcdda.europa.eu/ attachements.cfm/att-132857-EN-EMCDDA- Europol%20Annu al%20Report%202010A.pdf. Accessed Sept 2011
10. Ministry of Health, Labour and Welfare of Japan (2011). http://wwwhourei.mhlw.go.jp/hourei/doc/tsuchi/T110921I0010.pdf. Accessed 22 Sept 2011
11. Bononi M, Belgi P, Tateo F (2011) Analytical data for identification of the cannabimimetic phenylacetylindole JWH-203. J Anal Toxicol 35:360-363
12. Kitajima M, Misawa K, Kogure N, Said Ikram M, Horie S, Hatori Y, Murayama T, Takayama H (2006) A new indole alkaloid, 7-hydroxyspeciociliatine, from the fruits of Malaysian Mitragyna speciosa and its opioid agonistic activity. J Nat Med 60:28-35
13. Makriyannis A, Deng H (2008) Cannabimimetic indole derivatives, United States Patent, US 0090871 A1
14. Brents Lisa K, Reichard Emily E, Zimmerman Sarah M, Moran Jeffery H, Fantegrossi William E, Prather Paul L (2011) Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS ONE 6(7): e21917. doi:10.1371/journal.pone. 0021917
15. Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR (1998) Structure-activity relationships of indole and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 285:995-1004 (Pubitemid 28277896)
16. Monde T, Kamisuki T, Kuroda T, Mikumo K, Ohkawa T, Fukube H (1996) High-performance liquid chromatographic separation of phenols on a fluorocarbon-bonded silica gel column. J Chromatogr A 722:273-280 (Pubitemid 26054319)
17. Holler JM, Vorce SP, McDonough-Bender PC, Magluilo J Jr, Solomon CJ, Levine B (2011) A drug toxicity death involving propylhexedrine and mitragynine. J Anal Toxicol 35(1):54-59
18. EMCDDA (2009) Thematic papers: understanding the "Spice" phenomenon. http://www.emcdda.europa.eu/attachements.cfm/att- 80086-EN-Spice%20Thematic%20paper%20-%20final%20version. pdf. Accessed Oct 2011